928. Concordance with Institutional Guidelines for Letermovir Cytomegalovirus Infection Prophylaxis in Allogeneic Hematopoietic Stem Cell Transplant Recipients

BACKGROUND: Cytomegalovirus (CMV) is an opportunistic infection in immunocompromised patients associated with significant morbidity and mortality. Letermovir (LET) is used for prophylaxis for CMV-seropositive allogeneic hematopoietic stem cell transplant (HSCT) recipients. An institutional guideline...

Descripción completa

Detalles Bibliográficos
Autores principales: Peterson-Weber, Alex, Palisano, Nicholas, Alonso, Carolyn D
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Abstract
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10678233/
http://dx.doi.org/10.1093/ofid/ofad500.973

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10678233/
http://dx.doi.org/10.1093/ofid/ofad500.973

Ejemplares similares